PuSH - Publication Server of Helmholtz Zentrum München

Hoffmann, C.* ; Gerber, P.A.* ; Cavelti-Weder, C.* ; Licht, L.* ; Kotb, R.* ; Al Dweik, R.* ; Cherfane, M.* ; Bornstein, S.R.* ; Perakakis, N.

Liver, NAFLD and COVID-19.

Horm. Metab. Res. 54, 522-531 (2022)
Publ. Version/Full Text DOI PMC
Closed
Open Access Green as soon as Postprint is submitted to ZB.
Coronavirus disease 2019 (COVID-19) is characterized by a wide clinical spectrum that includes abnormalities in liver function indicative of liver damage. Conversely, people with liver diseases are at higher risk of severe COVID-19. In the current review, we summarize first the epidemiologic evidence describing the bidirectional relationship between COVID-19 and liver function/liver diseases. Additionally, we present the most frequent histologic findings as well as the most important direct and indirect mechanisms supporting a COVID-19 mediated liver injury. Furthermore, we focus on the most frequent liver disease in the general population, non-alcoholic or metabolic-associated fatty liver disease (NAFLD/MAFLD), and describe how COVID-19 may affect NAFLD/MAFLD development and progression and conversely how NAFLD/MAFLD may further aggravate a COVID-19 infection. Finally, we present the long-term consequences of the pandemic on the development and management of NAFLD.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
2.788
0.000
2
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Review
Keywords Covid-19 ; Liver ; Mafld ; Nafld ; Sars-cov-2
Language english
Publication Year 2022
HGF-reported in Year 2022
ISSN (print) / ISBN 0018-5043
e-ISSN 1439-4286
Quellenangaben Volume: 54, Issue: 8, Pages: 522-531 Article Number: , Supplement: ,
Publisher Thieme
Reviewing status Peer reviewed
Institute(s) Institute of Pancreatic Islet Research (IPI)
POF-Topic(s) 90000 - German Center for Diabetes Research
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-502600-012
Scopus ID 85132381183
PubMed ID 35468630
Erfassungsdatum 2022-08-31